First Nebraska Trust Co Purchases New Stake in Danaher Corporation $DHR

First Nebraska Trust Co purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 74,054 shares of the conglomerate’s stock, valued at approximately $14,106,000. Danaher makes up approximately 1.1% of First Nebraska Trust Co’s holdings, making the stock its 20th largest holding.

Several other institutional investors also recently bought and sold shares of DHR. BlackRock Inc. acquired a new stake in shares of Danaher in the second quarter worth $10,492,520,000. State Street Corp lifted its holdings in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after acquiring an additional 472,608 shares in the last quarter. Capital International Investors lifted its holdings in shares of Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after purchasing an additional 1,334,221 shares during the period. Finally, Wellington Management Group LLP boosted its position in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DHR has been the topic of several research reports. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Wells Fargo & Company reduced their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Stock Performance

Danaher stock opened at $219.42 on Friday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm’s fifty day moving average price is $195.80 and its 200 day moving average price is $192.61.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.77 EPS. On average, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.